Washington, DC: The US Food and Drug Administration (FDA) has issued an advisory for health care professionals concerning the use of antibiotic clarithromycin (Biaxin) in patients with heart disease. The issue is a potential increased risk of heart problems or death that can occur years later. The recommendation is based on a review of the results of a 10-year follow-up study of patients with coronary heart disease from a large clinical trial that first observed this safety issue................
This is Attorney AdvertisingTheClassActionNews.com is operated by the Law Offices of Jennifer Duffy, A Professional Law Corporation. Main Office: 4601 Wilshire Blvd, Los Angeles, CA 90010
We invite you to contact us and welcome your calls, letters and electronic mail. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.
The hiring of a lawyer is an important decision that should not be based solely upon advertisements. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Prior results do not guarantee a similar outcome. Submission of our contact form is an agreement to receive communication from entities related to TheClassActionNews.com. While the firm maintains joint responsibility, some cases are referred to other attorneys for principle responsibility.